Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Dexmedetomidine in paediatric anaesthesia: a call for action?

Evidence

Br J Anaesth. 2024 Jun 25:S0007-0912(24)00341-6. doi: 10.1016/j.bja.2024.05.029. Online ahead of print.

ABSTRACT

Dexmedetomidine is increasingly used in paediatric anaesthesia practice. In this issue of the British Journal of Anaesthesia, a retrospective hospital registry study in anaesthetised children showed that intraoperative use of dexmedetomidine was dose-dependently associated with a longer postanaesthesia care unit length of stay. Dexmedetomidine administration was also associated with higher total hospital costs and higher odds of unwarranted haemodynamic effects, while the onset of emergence delirium was not reduced. Although these results could curb enthusiasm for paediatric use of dexmedetomidine, they might also trigger discussion about our approach in the postoperative period to children having received dexmedetomidine intraoperatively.

PMID:38926029 | DOI:10.1016/j.bja.2024.05.029

Document this CPD Copy URL Button

Google

Google Keep

LinkedIn Share Share on Linkedin

Estimated reading time: 2 minute(s)

Latest: Psychiatryai.com #RAISR4D Evidence

Cool Evidence: Engaging Young People and Students in Real-World Evidence

Real-Time Evidence Search [Psychiatry]

AI Research

Dexmedetomidine in paediatric anaesthesia: a call for action?

Copy WordPress Title

🌐 90 Days

Evidence Blueprint

Dexmedetomidine in paediatric anaesthesia: a call for action?

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

More Evidence

Dexmedetomidine in paediatric anaesthesia: a call for action?

🌐 365 Days

Floating Tab
close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI RAISR 4D System Psychiatry + Mental Health